Greg Abel Is Buying Warren Buffett's Favorite Stock -- but He's Unlikely to End the 13-Quarter Net Selling Streak of Berkshire's Former Boss

Key event: Warren Buffett retired as CEO on Dec. 31 and Greg Abel has restarted Berkshire Hathaway share repurchases after a 21-month hiatus. Buffett spent roughly $78 billion on buybacks from July 2018–June 2024, while Berkshire recorded ~13 consecutive quarters of net stock sales totaling close to $187 billion; Abel faces $373.3 billion in cash/cash equivalents/Treasuries to deploy. Market context: S&P 500 Shiller P/E is ~39–41 (vs 155‑year average 17.35) and the Buffett indicator hit roughly 222%–224%, making bargains scarce despite Berkshire stock trading at a ~44% premium to book (two‑year low) that briefly justified buybacks.

Analysis

Management’s restart of repurchases should be read as a valuation-dependent allocation framework rather than a one-off liquidity deployment — expect buybacks to be the default lever when “sufficient” margin of safety returns and M&A to remain opportunistic until a clear, broad-market reset. That biases upside toward EPS/book-driven re-rating rather than profit-growth acceleration: fewer upward surprises from operating leverage, more from fewer shares outstanding and book-value mechanics.

Elevated aggregate market valuations amplify a mean-reversion tail risk: quant/ETF flows and high concentration in a handful of mega-caps can convert a modest sell signal into a multi-week liquidity vacuum, creating a narrow window where large corporate buyers can acquire assets at steep discounts. If a >15–25% market drawdown materializes within months, acquirers with patient balance sheets will capture outsized IRRs; absent that drawdown, cash-rich allocators will earn low returns held in short-duration paper.

Second-order winners include managers and asset owners who can redeploy float into stressed financials, regionals, and industrials — sectors where book-value-discount to replacement cost can open transactional opportunities. Losers are high-duration growth names and participants leveraged to continued multiple expansion; their forced selling in a liquidity crunch will both widen idiosyncratic spreads and create M&A ammunition for cash-rich buyers.

Practical implication: treat current buybacks as convexity-preserving rather than growth-enhancing. Positioning should therefore overweight optionality to buy into dislocations, hedge broad-index tail risk, and selectively favor large-cap balance-sheet optionality over momentum leadership.

Key Decisions for Investors

• Tactical long BRK.B (or BRK.A scaled equivalent) on meaningful pullback: accumulate on a 6–12% intraday decline from present levels, size 3–6% NAV, and buy 3–6 month protective puts (buy-write or put collar) to cap downside; R/R: limited upside near-term from buybacks but asymmetric if a market correction unlocks M&A (target 1.5–2.5x downside-protected return over 12 months).
• Pair trade: long BRK.B / short QQQ (1:1 notional) for 3–12 months to express capital-allocation resilience vs high-multiple growth exposure; this reduces beta while capturing mean-reversion if megacap leadership rolls over. Expected payoff: protection in drawdown, modest carry if buybacks compress float.
• Portfolio tail hedge: buy 3–6 month SPX or QQQ put spread (OTM) sized to cover 30–50% of equity exposure — aim to pay <1.5% of portfolio for protection that pays 6–10x beyond a 15% market drop. This preserves dry powder for opportunistic deployment without funding friction.
• Opportunistic idiosyncratic long: initiate a 12–24 month watchlist for mid-cap financials/industrial names with weak near-term earnings but strong franchise value; be ready to allocate 5–10% of excess cash to 1–3 of these names if prices dislocate by 30–40%, targeting >2.5x recovery IRR on mean-reversion exits.